292 related articles for article (PubMed ID: 26648693)
1. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.
Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ
Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693
[TBL] [Abstract][Full Text] [Related]
2. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.
Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ
Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217
[TBL] [Abstract][Full Text] [Related]
4. Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction.
Wang ZF; Wang NP; Harmouche S; Philip T; Pang XF; Bai F; Zhao ZQ
J Surg Res; 2017 May; 211():178-190. PubMed ID: 28501115
[TBL] [Abstract][Full Text] [Related]
5. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice.
Brosnihan KB; Hodgin JB; Smithies O; Maeda N; Gallagher P
Exp Physiol; 2008 May; 93(5):658-64. PubMed ID: 18192335
[TBL] [Abstract][Full Text] [Related]
7. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
8. Fibrous tissue and angiotensin II.
Sun Y; Ramires FJ; Zhou G; Ganjam VK; Weber KT
J Mol Cell Cardiol; 1997 Aug; 29(8):2001-12. PubMed ID: 9281434
[TBL] [Abstract][Full Text] [Related]
9. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
10. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.
Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ
Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859
[TBL] [Abstract][Full Text] [Related]
11. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
12. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
14. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
15. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
16. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.
Sriramula S; Cardinale JP; Lazartigues E; Francis J
Cardiovasc Res; 2011 Dec; 92(3):401-8. PubMed ID: 21952934
[TBL] [Abstract][Full Text] [Related]
17. Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart.
Pang XF; Zhang LH; Bai F; Wang NP; Ijaz Shah A; Garner R; Zhao ZQ
Eur J Pharmacol; 2015 Jan; 746():22-30. PubMed ID: 25445044
[TBL] [Abstract][Full Text] [Related]
18. CD44 Deficiency in Mice Protects the Heart Against Angiotensin Ii-Induced Cardiac Fibrosis.
Yang LW; Qin DZ; James E; McKallip RJ; Wang NP; Zhang WW; Zheng RH; Han QH; Zhao ZQ
Shock; 2019 Mar; 51(3):372-380. PubMed ID: 29470359
[TBL] [Abstract][Full Text] [Related]
19. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
